About: Caroline Bodet-Milin

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Caroline Bodet-Milin Goto Sponge NotDistinct Permalink

An Entity of Type : foaf:Person, within Data Space : data.idref.fr associated with source document(s)

Attributes	Values
type	Person
sameAs	Bodet-Milin, Caroline (1976-) Bodet-Milin, Caroline (1976-) Bodet-Milin, Caroline (1976-)
alternative label	Bodet, Caroline Milin Milin, Caroline Bodet-
Life Event	http://www.idref.fr/094593604/birth
preferred label	Bodet-Milin, Caroline (1976-)
name	Caroline Bodet-Milin
dbpedia-owl:citizenship	http://sws.geonames.org/3017382/
Language	http://lexvo.org/id/iso639-3/fra
isni:identifierValid	0000000123049796
Given name	Caroline
familyName	Bodet-Milin
has biographical i...tion (Deprecated)	Docteur en médecine. Travaille au sein du service de médecine nucléaire (en 2005) et est responsable de la plateforme TEP IRCNA du CHU de Nantes (2020)
gender	female
ORCID iD	0000-0002-8219-3592
org:hasMembership	http://www.idref.fr/094593604/affiliation/1 http://www.idref.fr/094593604/affiliation/2
org:memberOf	Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers (1979-....) Université de Nantes (1962-2021)
Scopus ID	6508098413
is sameAs of	Bodet-Milin, Caroline (1976-) Bodet-Milin, Caroline (1976-) Bodet-Milin, Caroline (1976-) Bodet-Milin, Caroline (1976-) Bodet-Milin, Caroline (1976-)
is Thesis advisor of	http://www.sudoc.fr/149280998/id http://www.sudoc.fr/157346080/id http://www.sudoc.fr/201017490/id http://www.sudoc.fr/197362796/id http://www.sudoc.fr/192267051/id Intérêt pronostic de la tomographie par émission de positons au 18FDG (TEP-FDG) à la rechute du myélome multiple Valeur pronostique de la tomographie par émission de positons au 18FDG (TEP-FDG) au diagnostic des patients atteints de lymphome à cellules du manteau inclus dans l'étude LyMa http://www.sudoc.fr/149280882/id http://www.sudoc.fr/197126936/id http://www.sudoc.fr/197127959/id Apport de la TEP au 18- FDG dans la stadification initiale et l'évaluation précoce de la réponse thérapeutique des rhabdomyosarcomes de l'enfant Apport de l'imagerie fonctionnelle par TEMP/TDM et TEP/TDM dans la prise en charge des cancers différenciés de la thyroïde http://www.sudoc.fr/241613531/id Intérêt pronostique et prédictif de la TEP-TDM au 18F-FDG initiale des mélanomes de stade III et IV avant traitement par immunothérapie http://www.sudoc.fr/244419434/id http://www.sudoc.fr/250550342/id http://www.sudoc.fr/250550458/id http://www.sudoc.fr/241613582/id Intérêt pronostique de la tomographie par émission de positions au 18FDG (TEP-TDM au 18FDG) au diagnostic initial du myélome multiple, analyse conjointe des études IFM/DFCI2009 et EMN02/HO95 http://www.sudoc.fr/274939053/id Apport du volume métabolique tumoral pour la stratification du risque dans le bilan initial des lymphomes B-diffus à grandes cellules http://www.sudoc.fr/282536515/id
is Praeses of	http://www.sudoc.fr/281902461/id http://www.sudoc.fr/263401022/id http://www.sudoc.fr/256600414/id http://www.sudoc.fr/265589150/id
is Author of	Optimisation clinique du pré-ciblage utilisant l'anticorps anti-ACE humanisé trivalent TF2 et le haptène bivalent IMP288 dans 2 modèles de tumeurs exprimant l'ACE, pour une application thérapeutique en radioimmunothérapie et pour une application en imagerie par émission de positon appelée immuno-TEP http://www.sudoc.fr/193512580/id http://www.sudoc.fr/193514540/id http://www.sudoc.fr/094593728/id Intérêt de la TEP au 18-FDG dans l'évaluation de la réponse à la radioimmunothérapie des patients porteurs de lymphomes malins non hodgkiniens traités par Yttrium-90 Epratuzumab http://www.sudoc.fr/14753934X/id Standardization of 18 F-FDG-PET/CT According to Deauville Criteria for Metabolic Complete Response Definition in Newly Diagnosed Multiple Myeloma Good clinical practice recommendations for the use of PET/CT in oncology Radioimmunoconjugates for treating cancer: recent advances and current opportunities Leveraging RSF and PET images for prognosis of Multiple Myeloma at diagnosis Clinical Results in Medullary Thyroid Carcinoma Suggest High Potential of Pretargeted Immuno-PET for Tumor Imaging and Theranostic Approaches Prognostic value of interim FDG PET/CT in Hodgkin's lymphoma patients treated with interim response-adapted strategy: comparison of International Harmonization Project (IHP), Gallamini and London criteria. Cardiac Metastasis from Medullary Thyroid Cancers with Long-Term Survival under Vandetanib ⁹⁰Y-labelled anti-CD22 epratuzumab tetraxetan in adults with refractory or relapsed CD22-positive B-cell acute lymphoblastic leukaemia: a phase 1 dose-escalation study Learned Deep Radiomics for Survival Analysis with Attention Ibrutinib, Obinutuzumab And Venetoclax In Relapsed and Untreated Patients with Mantle-Cell Lymphoma, a phase I/II trial Pretargeting for imaging and therapy in oncological nuclear medicine Predictive value of FDG‐PET imaging for relapse in metastatic melanoma patients treated with immunotherapy L'imagerie phénotypique du cancer du sein https://orbi.uliege.be/handle/2268/25901#id Added prognostic value of FDG-PET/CT in relapsing multiple myeloma patients Imaging of Monoclonal Gammapathy of Undetermined Significance and Smoldering Multiple Myeloma Radioimmunotherapy for Treatment of Acute Leukemia Report of the 6th International Workshop on PET in lymphoma Intérêt pronostique et prédictif de la TEP-TDM au 18F-FDG au bilan initial des mélanomes de stade IIIB-C-D et IV avant traitement par anti-PD-1 99mTc-MIBI pinhole SPECT in primary hyperparathyroidism: comparison with conventional SPECT, planar scintigraphy and ultrasonography. 18 F-Fludarabine PET for Lymphoma Imaging: First-in-Humans Study on DLBCL and CLL Patients Consolidation anti-CD22 fractionated radioimmunotherapy with 90 Y-epratuzumab tetraxetan following R-CHOP in elderly patients with diffuse large B-cell lymphoma: a prospective, single group, phase 2 trial What is the Best Radionuclide for Immuno-PET of Multiple Myeloma? A Comparison Study Between 89Zr- and 64Cu-Labeled Anti-CD138 in a Preclinical Syngeneic Model Revisiting the Robustness of PET-Based Textural Features in the Context of Multi-Centric Trials Whole-body MR imaging in suspected physical child abuse: comparison with skeletal survey and bone scintigraphy findings from the PEDIMA prospective multicentre study Prognostic value of FDG-PET indices for the assessment of histological response to neoadjuvant chemotherapy and outcome in pediatric patients with Ewing sarcoma and osteosarcoma Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of ΔSUVmax in the FDG-Avid Patients of the IMAJEM Study Immuno-PET Using Anticarcinoembryonic Antigen Bispecific Antibody and 68Ga-Labeled Peptide in Metastatic Medullary Thyroid Carcinoma: Clinical Optimization of the Pretargeting Parameters in a First-in-Human Trial Prospective Evaluation of Magnetic Resonance Imaging and [18F]Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography at Diagnosis and Before Maintenance Therapy in Symptomatic Patients With Multiple Myeloma Included in the IFM/DFCI 2009 Trial: Results of the IMAJEM Study [Update of the recommendations of good clinical practice for the use of PET in oncology]. Toxicity and efficacy of combined radioimmunotherapy and bevacizumab in a mouse model of medullary thyroid carcinoma. Comparison of Immuno-PET of CD138 and PET imaging with 64CuCl2 and 18F-FDG in a preclinical syngeneic model of multiple myeloma Sensitivity of pretargeted immunoPET using 68 Ga-peptide to detect colonic carcinoma liver metastases in a murine xenograft model: Comparison with 18 FDG PET-CT Prognostic value of F-18-FDG-PET in patients with mantle cell lymphoma: results from the LyMa-PET Project Reply https://orbi.uliege.be/handle/2268/3030#id 18F-FDG PET/CT in multiple myeloma: critical insights and future directions Functional Imaging for Therapeutic Assessment and Minimal Residual Disease Detection in Multiple Myeloma Exploring Tumor Heterogeneity Using PET Imaging: The Big Picture Obinutuzumab versus Rituximab in young patients with advanced DLBCL, a PET-guided and randomized phase 3 study by LYSA PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients Promising clinical performance of pretargeted immuno-PET with anti-CEA bispecific antibody and gallium-68-labelled IMP-288 peptide for imaging colorectal cancer metastases: a pilot study

Faceted Search & Find service v1.13.91 as of Aug 16 2018

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software